Next Generation News and Research

RSS

Researchers uncover new disease-linked microbial species through pan-body microbiome analysis

Researchers in Germany conducted a pan-body microbiome analysis, uncovering new microbial species and potential therapies linked to diseases, with implications for diagnostic and therapeutic advancements.

1 Oct 2024

ADA Forsyth Institute secures $6.2 million grant for innovative dental material research

The ADA Forsyth Institute (AFI) has been awarded a $6.2 million grant from the National Institute of Oral and Craniofacial Research (NIDCR). Funded under the highly competitive RM1 mechanism, this five-year award will support a groundbreaking project to develop next-generation smart materials for dental fillings using physics-based artificial intelligence (AI).

30 Sep 2024

New insights into macrophage function in acute kidney injury

Acute kidney injury (AKI) is associated with a poor prognosis, and no effective treatment has been established to date. Understanding the mechanisms that prevent the progression of AKI is crucial.

27 Sep 2024

Study reveals positive correlation between type 2 immunity and long-term cancer remission

Results from a preclinical study in mice, led by EPFL, and a collaborative clinical study in patients show that the type 2 immune response – associated with parasitic infection and thought to play a negative role in cancer immunity – is positively correlated with long-term cancer remission.

26 Sep 2024

Insufficient sleep during pregnancy associated with neurodevelopmental risks in offspring

Pregnant women who do not get enough sleep may be at higher risk of having children with neurodevelopmental delays, according to new research published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

26 Sep 2024

Wrist-based sensors provide insights into sunlight’s impact on depression

Wrist-based activity sensors worn by individuals with depression and those without over the course of two weeks provided evidence for the relationship between daily sunlight exposure and physical activity, according to a study published September 25, 2024, in the open-access journal PLOS Mental Health by Oleg Kovtun and Sandra Rosenthal from Vanderbilt University, U.S.

25 Sep 2024

Study links initial symptoms to long-term disability in multiple sclerosis

In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes.

24 Sep 2024

Broken String Biosciences appoints Laurence Reid and Brad Crutchfield to its Board of Directors

Broken String Biosciences enhances its leadership team with Laurence Reid and Brad Crutchfield, aiming to revolutionize cell and gene therapy development.

From Broken String Biosciences 23 Sep 2024

AB ANALITICA x SNIBE partnership – July 22, 2024

AB ANALITICA and SNIBE are proud to announce a distribution partnership in Italy for SNIBE Molecision R8 platform, and both companies will focus on the development and commercialization of next-generation molecular tests on this platform.

From AB ANALITICA 23 Sep 2024

Liraglutide activates key brain circuits to trigger weight loss in obesity

Researchers uncover how liraglutide targets specific brain regions to suppress appetite and promote significant weight loss through GLP-1 receptor activation.

23 Sep 2024

MaxCyte signs strategic platform license with Kamau Therapeutics to accelerate the development of cell therapies for genetic diseases

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, and Kamau Therapeutics, a clinical-stage stem cell therapy gene correction company, today announced they are entering into a strategic platform license (SPL) agreement.

From MaxCyte, Inc. 23 Sep 2024

Mount Sinai expands psychedelic research center with major donation from Parsons Foundation

Mount Sinai Health System this week celebrated the opening of an expansion of its psychedelic psychotherapy research center into a new location and announced a foundational $5 million gift from The Bob & Renee Parsons Foundation.

20 Sep 2024

UTA cancer researcher elected president of the American Society for Photobiology

University of Texas at Arlington cancer researcher Sherri McFarland has been elected president of the American Society for Photobiology (ASP), a national scientific organization dedicated promoting research related to the effects of light on human health and the broader natural world.

20 Sep 2024

FORT-2 trial shows promising results for bladder cancer immunotherapy combination

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients with locally advanced or metastatic bladder cancer.

19 Sep 2024

Phase 1 trial shows safety and efficacy of personalized vaccine for lymphoplasmacytic lymphoma

A team of researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and The University of Texas M.D. Anderson Cancer Center, have reported safety and efficacy results from a Phase 1 trial that featured a personalized vaccine to treat lymphoplasmacytic lymphoma, a rare and slow-growing type of blood cancer, according to a study published recently in Nature Communications.

19 Sep 2024

Study highlights disparities in stroke burden across regions

Although stroke is highly preventable and treatable, there has been a rapid rise in the global stroke burden between 1990 and 2021, due to both population growth and the rise of aging populations worldwide, as well as a substantial increase in people's exposure to environmental and behavioral risk factors.

19 Sep 2024

New biomarkers offer hope for early detection and prevention of Alzheimer's

The failure to diagnose Alzheimer's disease, the most common form of dementia in the elderly, at an early stage of molecular pathology is considered a major reason why treatments fail in clinical trials. Previous research to molecularly diagnose Alzheimer's disease yielded "A/T/N" central biomarkers based on the measurements of proteins, β-amyloid ("A") and tau ("T"), and "N" encompassing neurodegeneration. A/T/N can be measured in brain tissue, by in vivo brain imaging techniques, and by analysis of cerebrospinal fluid and plasma.

18 Sep 2024

Survey reveals significant gaps in global pandemic preparedness

Abbott announced the findings of a new survey; among leading infectious disease experts around the world on the state of pandemic preparedness and found that while most agree that preparation has improved since the COVID-19 pandemic, respondents say significant gaps remain in building surveillance programs to identify emerging pathogens, public health funding and having adequate testing infrastructure capabilities.

18 Sep 2024

New $3.26 million grant launches Undiagnosed Diseases Network site in New York

A new four-year, $3.26 million grant from the National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of Health (NIH), establishes the first Undiagnosed Diseases Network (UDN) site in the New York metropolitan area.

17 Sep 2024

Huntsman Cancer Institute celebrates 25 years of innovations in cancer research and care

On September 13, 2024, Huntsman Cancer Institute at the University of Utah (the U), the National Cancer Institute-designated cancer center for the Mountain West, celebrates 25 years of groundbreaking cancer research, education, and patient care.

13 Sep 2024

Next Generation News and Research

Researchers uncover new disease-linked microbial species through pan-body microbiome analysis

ADA Forsyth Institute secures $6.2 million grant for innovative dental material research

New insights into macrophage function in acute kidney injury

Study reveals positive correlation between type 2 immunity and long-term cancer remission

Insufficient sleep during pregnancy associated with neurodevelopmental risks in offspring

Wrist-based sensors provide insights into sunlight’s impact on depression

Study links initial symptoms to long-term disability in multiple sclerosis

Broken String Biosciences appoints Laurence Reid and Brad Crutchfield to its Board of Directors

AB ANALITICA x SNIBE partnership – July 22, 2024

Liraglutide activates key brain circuits to trigger weight loss in obesity

MaxCyte signs strategic platform license with Kamau Therapeutics to accelerate the development of cell therapies for genetic diseases

Mount Sinai expands psychedelic research center with major donation from Parsons Foundation

UTA cancer researcher elected president of the American Society for Photobiology

FORT-2 trial shows promising results for bladder cancer immunotherapy combination

Phase 1 trial shows safety and efficacy of personalized vaccine for lymphoplasmacytic lymphoma

Study highlights disparities in stroke burden across regions

New biomarkers offer hope for early detection and prevention of Alzheimer's

Survey reveals significant gaps in global pandemic preparedness

New $3.26 million grant launches Undiagnosed Diseases Network site in New York

Huntsman Cancer Institute celebrates 25 years of innovations in cancer research and care

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News